What does an elevated melanocyte‑stimulating hormone (MSH) suggest?

Elevated Melanocyte-Stimulating Hormone (MSH): Clinical Significance

An elevated melanocyte-stimulating hormone (MSH) level most importantly suggests primary adrenal insufficiency (Addison's disease), as MSH is co-secreted with ACTH from the pituitary gland in response to low cortisol levels.

Primary Diagnostic Consideration: Adrenal Insufficiency

When you encounter elevated MSH, your first concern should be primary adrenal insufficiency (PAI). Here's the pathophysiologic reasoning:

• MSH and ACTH share a common precursor molecule (proopiomelanocortin/POMC) and are cleaved together in the pituitary gland
• In PAI, the adrenal glands fail to produce adequate cortisol despite maximal pituitary stimulation
• This results in simultaneous elevation of both ACTH and MSH
• The elevated MSH causes the characteristic hyperpigmentation seen in Addison's disease, particularly in sun-exposed areas, skin creases, and mucous membranes

Diagnostic Workup for PAI

When MSH elevation suggests adrenal insufficiency, confirm the diagnosis with 1:

1. Measure plasma ACTH - In confirmed cortisol deficiency, ACTH ≥2-fold the upper limit of normal is consistent with PAI
2. Morning cortisol - Low cortisol (<140 nmol/L or <5 μg/dL) paired with elevated ACTH indicates adrenal cortex failure
3. Corticotropin stimulation test - Either high-dose (250 μg) or low-dose (1 μg) can confirm inadequate adrenal response
4. Plasma renin and aldosterone - Simultaneously measure these to determine mineralocorticoid deficiency, as elevated renin with inappropriately normal/low aldosterone suggests PAI 1

Important caveat: Elevated ACTH with normal-range cortisol can be the first sign of early-stage PAI, so don't dismiss the possibility if cortisol isn't frankly low 1.

Secondary Considerations

Salt-Sensitive Hypertension

Gamma-MSH (another MSH variant) plays a role in blood pressure regulation. Deficiency in gamma-MSH processing leads to salt-sensitive hypertension 2. However, this is typically a research finding rather than a clinical diagnostic consideration when measuring MSH levels.

Dermatologic Context

In non-endocrine contexts, MSH has multiple skin-related functions 3, 4:

• Melanogenesis and pigmentation regulation
• Anti-inflammatory and immunomodulatory effects
• UV protection responses
• Keratinocyte proliferation modulation

Clinical pitfall: Unregulated use of synthetic MSH analogues (melanotan I and II) for tanning purposes has been associated with melanocytic changes and potentially melanoma development 5. Always inquire about use of these substances when evaluating patients with unusual pigmentation or new/changing nevi.

Algorithmic Approach to Elevated MSH

1. First: Assess for clinical signs of adrenal insufficiency (hyperpigmentation, hypotension, fatigue, weight loss, salt craving)
2. Second: Obtain morning cortisol and ACTH levels simultaneously
3. Third: If cortisol is low-normal or low with elevated ACTH, proceed with corticotropin stimulation test
4. Fourth: Measure renin and aldosterone to assess mineralocorticoid status
5. Fifth: Determine etiology of PAI once confirmed (autoimmune, infectious, genetic, etc.) 1

The bottom line: Treat elevated MSH as a red flag for primary adrenal insufficiency until proven otherwise, as this represents a potentially life-threatening condition requiring prompt glucocorticoid replacement therapy.